Hormonal factors and the laboratory detection of Chlamydia trachomatis in women: Implications for screening?

International Journal of STD and AIDS

Volumn 8, Issue 1, 1997, Pages 25-31

  Crowley, Tessa ^a   Horner, Patrick ^a   Hughes, Anthony ^b   Berry, Judith ^a   Paul, Ian ^c   Caul, Owen ^c  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Chlamydia trachomatis; hormonal contraception; menstrual cycle

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; FEMALE; GENITAL TRACT INFECTION; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; ORAL CONTRACEPTION; PRIORITY JOURNAL;

BIOLOGY; CERVIX; CHLAMYDIA; CLINICAL RESEARCH; CONTRACEPTION; CONTRACEPTIVE METHODS; DEVELOPED COUNTRIES; DISEASES; ENGLAND; EUROPE; EXAMINATIONS AND DIAGNOSES; FAMILY PLANNING; GENITALIA; GENITALIA, FEMALE; INCIDENCE; INFECTIONS; MEASUREMENT; MENSTRUAL CYCLE; MENSTRUATION; NORTHERN EUROPE; ORAL CONTRACEPTIVES; ORAL CONTRACEPTIVES, COMBINED; PHYSIOLOGY; REPRODUCTION; REPRODUCTIVE TRACT INFECTIONS; RESEARCH METHODOLOGY; RESEARCH REPORT; SCREENING; SEXUALLY TRANSMITTED DISEASES; UNITED KINGDOM; UROGENITAL SYSTEM; UTERUS;

ADOLESCENT; ADULT; CERVIX UTERI; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CONTRACEPTIVES, ORAL; FEMALE; GREAT BRITAIN; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; URETHRA;

EID: 0031032992     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462971918724     Document Type: Article

References (38)

1. Westrom L, Wolner-Hanssen P. Pathogenesis of pelvic inflammatory disease. Genitourin Med 1993;69:9-17
2. Westrom L. Pelvic inflammatory disease. JAMA 1991;266:2612
3. Healy DL, Trounson AO, Anderson AN. Female infertility: causes and treatment. Lancet 1994;343:1539-44
4. Taylor-Robinson D. Chlamydia trachomatis and sexually transmitted disease. BMJ 1993;308:150-1
5. Mardh PA, Paavonen J, Puolakkainen M. Genital Chlamydial Infections. New York: Plenum Medical, 1989;121
6. Crowley T, Milne D, Arumainayagam JT, Paul ID, Caul EO. The laboratory diagnosis of male Chlamydia trachomatis infections - a time for change? J Infection 1992;25:69-75
7. Singh G, Blackwell A. Morbidity in male partners of women who have chlamydial infection before termination of pregnancy. Lancet 1994;344:1438
8. Taylor-Robinson D, Thomas BJ. Laboratory techniques for the diagnosis of chlamydial infections. Genitourin Med 1991;67:256-66
9. Paavonen J. Chlamydia trachomatis-induced urethritis in female partners of men with nongonococcal urethritis. Sex Trans Dis 1979;6:69-71
10. Hay P, Thomas BJ, Horner PJ, Macleod E, Renton AM, Taylor-Robinson D. Chlamydia trachomatis in women: the more you look the more you find. Genitourin Med 1994;70:97-100
11. Hilton AL, Richmond SJ, Milne JD, Hindley F, Clarke SKR. Chlamydia A in the female genital tract. Br J Vener Dis 1974;50:1-9
12. Rosenthal GE, Landefeld CS. The relation of chlamydial infection of the cervix to time elapsed from the onset on menses. J Clin Epidemiol 1990;43:15-20
13. Caul EO, Paul ID. Monoclonal antibody based ELISA for detecting Chlamydia trachomatis. Lancet 1985;i:279
14. Paul ID, Caul EO. Evaluation of three Chlamydia trachomatis immunoassays with an unbiased, non-invasive clinical sample. J Clin Microbiol 1990;28:220-2
15. Cottingham J, Hunter D. Chlamydia trachomatis and oral contraceptive use a quantitative review. Genitourin Med 1992;68:209-16
16. Arya OP, Mallinson H, Goddard AD. Epidemiological and clinical correlates of chlamydial infection of the cervix. Br J Vener Dis 1981;57:118-24
17. Tait A, Rees E, Hobson D, Byng RE, Tweedie MCK. Chlamydial infection of the cervix in contacts of men with nongonococcal urethritis. Br J Vener Dis 1979;56:37-45
18. Oriel JD, Johnson AL, Barlow D, Thomas BJ, Nayyar K, Reeve P. Infection of the uterine cervix with Chlamydia trachomatis. J Infect Dis 1978;137:443-51
19. Thejls H, Gnarpe J, Gnarpe Haken, et al. Expanded gold standard in the diagnosis of Chlamydia trachomatis in a low prevalence population: diagnostic efficacy of tissue culture, direct immunofluorescence, enzyme immunoassay, PCR and serology. Genitourin Med 1994;70:300-3
20. Brunham RC, Kuo C-C, Cles L, Holmes KK. Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun 1983;39:1491-4
21. Kellog A. Clinical and laboratory considerations of culture vs antigen assays for detection of Chlamydia trachomatis from genital specimens. Arch Pathol Lab Med 1989;113:453-9
22. Gann HP, Herrman JE, Candib L, Hudson RW. Accuracy of Chlamydia trachomatis detection methods in a low prevalence population in a primary care setting. J Clin Microbiol 1990;28:1580-5
23. Cooper MD, Sheldon AA. Effect of hormones on infectivity of Chlamydia trachomatis in the human fallopian tube organ culture. In: Orfila J, Byrne GI, Chernesky MA, et al., eds. Chlamydial infections (Proceedings of the eighth International Symposium). Bologna-Italy: Societa Editnee Esculapio, 1994;431-4
24. Maslow AS, Davis CH, Choong J, Wyrick PB. Estrogen enhances attachment of Chlamydia trachomatis to human endometrial cells in vitro. Am J Obstet Gynecol 1988;159:1006-14
25. Bose SK, Goswami PC. Enhancement of adherence and growth of Chlamydia trachomatis by estrogen treatment of HeLa cells. Infect Immun 1986;53:646-50
26. Ito JI, Harrison HR, Alexander ER, Billings LJ. Establishment of genital tract infection in the CF-1 mouse by intravaginal inoculation of a human oculogenital isolate of Chlamydia trachomatis. J Infect Dis 1984;150:577-82
27. Tuffrey M, Falder P, Taylor-Robinson D. Genital tract infection and disease in nude and immunologically competent mice after inoculation of a human strain of Chlamydia trachomatis. Br J Exp Pathol 1982;63:539-46
28. Pasley JN, Rank RG, Hough AJ, Cohen C, Barron AL. Effects of various doses of estradiol on chlamydial genital infection in ovariectomized guineapigs. Sex Trans Dis 1985;12:8-13
29. Rank RG, Sanders MM, Kidd AT. Influence of the estrus cycle on the development of upper genital tract pathology as a result of chlamydial infection in the guineapig model of pelvic inflammatory disease. Am J Path 1993;142:1291-6
30. Barron AL, Pasley JN, Rank RG, White HJ, Mrak RE. Chlamydial salpingitis in female guineapigs receiving oral contraceptives. Sex Trans Dis 1988;15:169-73
31. Zuckerman H, Kahana A, Carmel S. Antibacterial activity of human cervical mucus. Gynecol Invest 1975;6:265-71
32. Mahmoud EA, Hamad EE, Bassiri M, Mardh P-A. Antichlamydial activity of cervical secretion. J Obstet Gynaecol 1994;14:166-71
33. Elgaali A, Mahmoud EA, Hamad EE, Olsson SE, Mardh P-A. Antichlamydial activity of cervical secretion in different phases of the menstrual cycle and the influence of hormonal contraceptives. Contraception 1994;49:265-74
34. Hasty LA, Lambris JD, Lessey BA, Pruksananonda K, Lyttle RC. Hormonal regulation of complement components and receptors throughout the menstrual cycle. Am J Obstet Gynecol 1994;170:168-75
35. Harvey SM. Female sexual behaviour: fluctuations during the menstrual cycle. J Psychosomatic Res 1987;31:101-10
36. Slob AK, Ernste M, van der Werff ten Bosch JJ. Menstrual cycle phase and sexual arousability in women. Arch Sex Behav 1991;20:567-77
37. Alexander GM, Sherwin BB, Bancroft J, Davidson DW. Testosterone and sexual behaviour in oral contraceptive users and nonusers: a prospective study. Horm Behav 1990;24:388-402
38. Hobson D, Karayiannis P, Byng RE, Rees E, Tait AI, Davies JA. Quantitative aspects of chlamydial infection of the cervix. Br J Vener Dis 1980;56:156-62